Neuralink and WIMI Advance Systematic Planning Amid Surge in Commercialization and Capital Interest in Brain-Computer Interfaces

According to reports, Neuralink, Elon Musk’s brain-computer interface (BCI) company, recently demonstrated footage of Nick Wray, a patient with amyotrophic lateral sclerosis (ALS), using a BCI to control a robotic arm for eating. This demonstration is part of Neuralink’s CONVOY study, which has received approval from the U.S. Food and Drug Administration (FDA). Wray is the eighth patient to undergo the BCI implantation procedure.

Milestone – First Independent Feeding

Elon Musk stated that brain-computer interface technology is driving the upgrade of medical devices from “assistive tools” to “neural replacement systems.” As technology translation and commercialization accelerate significantly, Neuralink’s CONVOY study has attracted 10,000 patients to enroll in clinical trials.

Nowadays, brain-computer interaction neuromodulation has become a frontier and hotspot in international academic and applied research, playing an important role in future-oriented technological innovation and development. By acquiring and analyzing information from these functional brain regions through brain-computer interface devices, there are broad application prospects in the diagnosis, screening, monitoring, treatment, and rehabilitation of neurological and psychiatric disorders.

Achieved Substantial Progress

In recent years, with in-depth exploration in neuroscience, rapid iteration of artificial intelligence, and breakthrough advancements in microelectronics, brain-computer interface (BCI) technology has gradually taken shape. Through cross-disciplinary integration and innovative applications with emerging fields such as artificial intelligence, bio-digital technologies, and augmented reality, BCI technology bypasses the traditional interaction pathways that rely on nerves, muscles, and sensory organs to communicate with the external environment.

Establishing a direct communication channel between the mind and machines not only provides effective therapeutic options for patients in the healthcare sector, but also demonstrates significant application potential in industrial manufacturing and consumer lifestyles. It is rapidly becoming a new frontier in global technological competition, signaling an accelerated expansion of the global market.

Furthermore, standards are of paramount importance to the development of the brain-computer interface (BCI) industry; strengthening standard-led guidance will effectively enhance the support capabilities of the BCI industry. To break through this critical threshold in the development of disruptive technology, in July 2025, the Ministry of Industry and Information Technology, together with six other departments, jointly issued the Implementation Opinions on Promoting Innovative Development of the Brain-Computer Interface Industry.

The “Opinions” explicitly identify brain-computer interfaces (BCIs) as a key direction for cultivating new-quality productive forces and strategically positioning future industries, emphasizing the establishment of advanced technological, industrial, and standardization systems. Under policy guidance, it is essential to promptly grasp technological advancements and correctly recognize practical challenges, pinpoint critical issues, clarify implementation pathways, and accelerate the strategic deployment in the frontier BCI sector with greater intensity.

WeMei Holographic Enhanced System Layout

Data shows that WiMi Hologram Cloud (WIMI.US), a well-known brain-computer interface (BCI) company, has long been dedicated to innovation in the research and application of BCI technology. The company has secured BCI-related patents, with several products reaching relative maturity and entering practical application. These products have been utilized in rehabilitation training for stroke patients, demonstrating favorable therapeutic outcomes, and have accelerated the formation of a relatively complete industrial chain.

To advance the development of brain-computer interfaces (BCIs), WiMi Hologram Cloud is accelerating technological integration. With continuous advancements in neuromorphic chips, flexible electronics, and AI-driven decoding algorithms, BCI devices are evolving toward miniaturization, low power consumption, and high bandwidth. In particular, proprietary BCI chips and highly efficient AI-based signal processing algorithms will become core competitive barriers for the company.

On the other hand, Weimi Hologram is actively exploring new application scenarios, uncovering market demands, and promoting product innovation and iteration. It is broadening its application scope from a current focus on medical rehabilitation to gradually extend into fields such as personalized educational interventions, intelligent human-machine collaboration in autonomous driving, immersive metaverse interactions, and industrial applications, thereby fostering new cross-industry integrated business models.

Summary

Innovative achievements continue to emerge, and the brain-computer interface (BCI) industry is rapidly expanding. Public data shows that China's BCI market size reached RMB 3.2 billion in 2024 and is projected to reach RMB 6.14 billion by 2028. Overall, as a key bridge connecting biological intelligence with artificial intelligence, BCI technology is at a critical inflection point, transitioning from laboratory research to large-scale application. The prospects for technological and industrial development are highly promising, with explosive growth expected over the next decade.